Healthcare provider profile · identity verified

Craig J Recko, MD

Allopathic & Osteopathic Physicians|Family Medicine · VERMILION, OH · NPI 1578783486

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Craig J Recko, MD received $14.82 in general payments during 2025 across 1 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Armour Thyroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 84 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VIBERZI as an associated drug or biological on 11354 records involving 5020 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Viberzi by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$14.82

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$14.82	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$14.82	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$14.82	1	2025
Source payment records 2025-02-19 · ABBVIE INC. · $14.82 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	ARMOUR THYROID open payments reported associated product	CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088	Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	84	24
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VIBERZI open payments reported associated product	CMS Open Payments — General Payments 11354 supporting records · 5020 recipient NPIs · example record 1201352948	Viberzi · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	819	189
Atorvastatin Calcium	Atorvastatin Calcium	690	170
Amlodipine Besylate	Amlodipine Besylate	643	168
Omeprazole	Omeprazole	498	122
Pantoprazole Sodium	Pantoprazole Sodium	384	88
Lisinopril	Lisinopril	369	91
Metoprolol Tartrate	Metoprolol Tartrate	355	80
Pravastatin Sodium	Pravastatin Sodium	349	80
Albuterol Sulfate Hfa	Albuterol Sulfate	337	98
Tamsulosin Hcl	Tamsulosin Hcl	333	85
Alprazolam	Alprazolam	325	54
Metformin Hcl	Metformin Hcl	307	72
Gabapentin	Gabapentin	303	72
Hydrochlorothiazide	Hydrochlorothiazide	284	78
Metoprolol Succinate	Metoprolol Succinate	274	72
Simvastatin	Simvastatin	263	60
Sertraline Hcl	Sertraline Hcl	256	60
Metformin Hcl Er	Metformin Hcl	251	58
Allopurinol	Allopurinol	243	54
Losartan Potassium	Losartan Potassium	241	65
Trazodone Hcl	Trazodone Hcl	233	49
Duloxetine Hcl	Duloxetine Hcl	226	53
Clopidogrel	Clopidogrel Bisulfate	223	50
Furosemide	Furosemide	221	65
Meloxicam	Meloxicam	218	56
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	197	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	45
Methylprednisolone	Methylprednisolone	169	137
Glimepiride	Glimepiride	166	35
Bupropion Xl	Bupropion Hcl	164	42
Carvedilol	Carvedilol	159	39
Prednisone	Prednisone	158	80
Rosuvastatin Calcium	Rosuvastatin Calcium	152	47
Tramadol Hcl	Tramadol Hcl	146	44
Citalopram Hbr	Citalopram Hydrobromide	145	28
Famotidine	Famotidine	140	33
Potassium Chloride	Potassium Chloride	132	43
Celecoxib	Celecoxib	131	35
Escitalopram Oxalate	Escitalopram Oxalate	128	28
Tizanidine Hcl	Tizanidine Hcl	123	48
Atenolol	Atenolol	114	29
Fluticasone Propionate	Fluticasone Propionate	114	49
Finasteride	Finasteride	112	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	101	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	101	31
Montelukast Sodium	Montelukast Sodium	101	22
Januvia	Sitagliptin Phosphate	97	24
Zolpidem Tartrate	Zolpidem Tartrate	96	18
Buspirone Hcl	Buspirone Hcl	90	14
Mirtazapine	Mirtazapine	86	21
Azithromycin	Azithromycin	84	68
Synthroid	Levothyroxine Sodium	84	24
Ibuprofen	Ibuprofen	83	24
Hydroxyzine Hcl	Hydroxyzine Hcl	82	27
Xarelto	Rivaroxaban	82	18
Olmesartan Medoxomil	Olmesartan Medoxomil	81	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	79	40
Spironolactone	Spironolactone	78	17
Donepezil Hcl	Donepezil Hcl	76	24
Lorazepam	Lorazepam	76	16
Eliquis	Apixaban	75	23
Pregabalin	Pregabalin	75	15
Paroxetine Hcl	Paroxetine Hcl	74	14
Clonazepam	Clonazepam	69	12
Fluoxetine Hcl	Fluoxetine Hcl	67	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	17
Oxybutynin Chloride Er	Oxybutynin Chloride	66	23
Pioglitazone Hcl	Pioglitazone Hcl	64	14
Meclizine Hcl	Meclizine Hcl	62	25
Dicyclomine Hcl	Dicyclomine Hcl	61	22
Ezetimibe	Ezetimibe	61	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	16
Doxycycline Hyclate	Doxycycline Hyclate	56	27
Ozempic	Semaglutide	56	11
Esomeprazole Magnesium	Esomeprazole Magnesium	55	13
Venlafaxine Hcl Er	Venlafaxine Hcl	55	suppressed
Diclofenac Sodium	Diclofenac Sodium	54	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	14
Aripiprazole	Aripiprazole	50	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	50	13
Valacyclovir	Valacyclovir Hcl	50	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	46	suppressed
Lovastatin	Lovastatin	44	12
Torsemide	Torsemide	44	11
Ventolin Hfa	Albuterol Sulfate	44	16
Ondansetron Odt	Ondansetron	43	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	13
Levetiracetam	Levetiracetam	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Rybelsus	Semaglutide	40	suppressed
Testosterone Cypionate	Testosterone Cypionate	40	14
Fenofibrate	Fenofibrate Nanocrystallized	39	suppressed
Mounjaro	Tirzepatide	39	suppressed
Fenofibrate	Fenofibrate	38	12
Levofloxacin	Levofloxacin	38	27
Combivent Respimat	Ipratropium/Albuterol Sulfate	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	32	14
Lantus	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Diazepam	Diazepam	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Fluocinonide	Fluocinonide	27	14
Valsartan	Valsartan	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	14
Terazosin Hcl	Terazosin Hcl	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Cephalexin	Cephalexin	25	11
Glipizide	Glipizide	25	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Colchicine	Colchicine	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	24	suppressed
Primidone	Primidone	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Naproxen	Naproxen	23	11
Nitroglycerin	Nitroglycerin	23	11
Otezla	Apremilast	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Mupirocin	Mupirocin	22	17
Amoxicillin	Amoxicillin	21	12
Fluconazole	Fluconazole	20	13
Hydrocortisone	Hydrocortisone	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Topiramate	Topiramate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Baclofen	Baclofen	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Nystatin	Nystatin	15	suppressed
Ramipril	Ramipril	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	14	suppressed
Cefdinir	Cefdinir	14	13
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Np Thyroid	Thyroid,pork	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Digoxin	Digoxin	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Ibu	Ibuprofen	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Viberzi	Eluxadoline	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$14.82 · 1 records	ABBVIE INC.	VRAYLAR	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error